165 related articles for article (PubMed ID: 15108220)
1. Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable?
Ducongé J; Fernández-Sánchez E; Alvarez D
Biopharm Drug Dispos; 2004 May; 25(4):177-86. PubMed ID: 15108220
[TBL] [Abstract][Full Text] [Related]
2. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
[TBL] [Abstract][Full Text] [Related]
3. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Shim HJ; Kim YC; Lee JH; Kwon JW; Kim WB; Kim YG; Kim SH; Lee MG
Biopharm Drug Dispos; 2005 Oct; 26(7):269-77. PubMed ID: 15991256
[TBL] [Abstract][Full Text] [Related]
4. Interspecies scaling of clearance and volume of distribution for horse antivenom F(ab')2.
Bazin-Redureau M; Pepin S; Hong G; Debray M; Scherrmann JM
Toxicol Appl Pharmacol; 1998 Jun; 150(2):295-300. PubMed ID: 9653060
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of monoclonal anti-epidermal growth factor receptor antibody (IOR EGF/r3)-induced apoptosis in human carcinoma bearing nude mice.
Ducongé J; Merino N; Alvarez D; Beausoleil I; Fernández-Sánchez E; Rodríguez L; Burt AD
P R Health Sci J; 2008 Mar; 27(1):35-41. PubMed ID: 18450231
[TBL] [Abstract][Full Text] [Related]
6. Interspecies scaling of clearance and volume of distribution for digoxin-specific Fab.
Grene-Lerouge NA; Bazin-Redureau MI; Debray M; Scherrmann JM
Toxicol Appl Pharmacol; 1996 May; 138(1):84-9. PubMed ID: 8658517
[TBL] [Abstract][Full Text] [Related]
7. Interspecies scaling of therapeutic monoclonal antibodies: initial look.
Ling J; Zhou H; Jiao Q; Davis HM
J Clin Pharmacol; 2009 Dec; 49(12):1382-402. PubMed ID: 19837907
[TBL] [Abstract][Full Text] [Related]
8. Application of interspecies scaling to the bispyridinium oxime HI-6.
Baggot JD
Am J Vet Res; 1994 May; 55(5):689-91. PubMed ID: 8067618
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and interspecies scaling of recombinant human factor VIII.
Mordenti J; Osaka G; Garcia K; Thomsen K; Licko V; Meng G
Toxicol Appl Pharmacol; 1996 Jan; 136(1):75-8. PubMed ID: 8560482
[TBL] [Abstract][Full Text] [Related]
10. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor.
Crombet T; Torres O; Neninger E; Catalá M; Rodríguez N; Ramos M; Fernández E; Iznaga N; Pérez R; Lage A
Cancer Biother Radiopharm; 2001 Feb; 16(1):93-102. PubMed ID: 11279803
[TBL] [Abstract][Full Text] [Related]
11. Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
Crombet T; Osorio M; Cruz T; Roca C; del Castillo R; Mon R; Iznaga-Escobar N; Figueredo R; Koropatnick J; Renginfo E; Fernández E; Alvárez D; Torres O; Ramos M; Leonard I; Pérez R; Lage A
J Clin Oncol; 2004 May; 22(9):1646-54. PubMed ID: 15117987
[TBL] [Abstract][Full Text] [Related]
12. Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans.
Richter WF; Gallati H; Schiller CD
Drug Metab Dispos; 1999 Jan; 27(1):21-5. PubMed ID: 9884305
[TBL] [Abstract][Full Text] [Related]
13. Interspecies scaling of a camptothecin analogue: human predictions for intravenous topotecan using animal data.
Ahlawat P; Srinivas NR
Xenobiotica; 2008 Nov; 38(11):1377-85. PubMed ID: 18946781
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-antiepidermal growth factor-receptor antibody in patients with tumors of epithelial origin: part II. Pharmacokinetics and clearances.
Iznaga-Escobar N; Torres Arocha LA; Morales Morales A; Ramos Suzarte M; Rodríguez Mesa N; Pérez Rodríguez R
J Nucl Med; 1998 Nov; 39(11):1918-27. PubMed ID: 9829584
[TBL] [Abstract][Full Text] [Related]
15. Disposition kinetics of human epidermal growth factor (hEGF1-53) and its truncated fragment (hEGF1-48) in rats.
Kuo BS; Nordblom GD; Dudeck RC; Kirkish LS; Wright DS
Drug Metab Dispos; 1996 Jan; 24(1):96-104. PubMed ID: 8825196
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans.
Paxton JW; Kim SN; Whitfield LR
Cancer Res; 1990 May; 50(9):2692-7. PubMed ID: 2328494
[TBL] [Abstract][Full Text] [Related]
17. Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations.
Martinez M; Mahmood I; Hunter RP
J Vet Pharmacol Ther; 2006 Oct; 29(5):425-32. PubMed ID: 16958788
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of humanized monoclonal anti-IL-13 antibodies with different IL-13 neutralization mechanisms.
Vugmeyster Y; Szklut P; Tchistiakova L; Abraham W; Kasaian M; Xu X
Int Immunopharmacol; 2008 Mar; 8(3):477-83. PubMed ID: 18279802
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic scaling of SJ-8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species-invariant time methods.
Shin BS; Kim DH; Cho CY; Park SK; Chung SG; Cho EH; Lee SH; Joo JH; Kwon HS; Lee KC; Yoo SD
Biopharm Drug Dispos; 2003 Jul; 24(5):191-7. PubMed ID: 12784318
[TBL] [Abstract][Full Text] [Related]
20. Interspecies scaling of the pharmacokinetic parameters of coumarin among six different mammalian species.
Ritschel WA; Vachharajani NN; Johnson RD; Hussain AS
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):697-702. PubMed ID: 1770833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
